Marin Cancer Center

Greenbrae, California 94904

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, ER Positive, Her2 Negative Breast Cancer Patients, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Metastatic Head and Neck Cancer, Multiple Myeloma, Neoplasms, Head and Neck, Recurrent Head and Neck Cancer, Triple Negative Breast Cancer Patients

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC — Completed
• A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment — Completed
• A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer — Completed